8.83 USD
-0.13 (-1.45%)
8.83 USD
0 (0%)
JYNT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. JYNT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. JYNT has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year JYNT has reported negative net income.
JYNT had a positive operating cash flow in the past year.
In multiple years JYNT reported negative net income over the last 5 years.
Each year in the past 5 years JYNT had a positive operating cash flow.
1.2 Ratios
JYNT has a Return On Assets (-1.40%) which is in line with its industry peers.
JYNT's Return On Equity of -4.27% is in line compared to the rest of the industry. JYNT outperforms 47.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.4% | ||
| ROE | -4.27% | ||
| ROIC | N/A |
ROA(3y)-7.05%
ROA(5y)1.52%
ROE(3y)-28.39%
ROE(5y)0.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 78.26%, JYNT belongs to the top of the industry, outperforming 93.07% of the companies in the same industry.
JYNT's Gross Margin has declined in the last couple of years.
JYNT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 78.26% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.87%
GM growth 5Y-2.53%
2. Health
2.1 Basic Checks
JYNT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for JYNT has been increased compared to 1 year ago.
Compared to 5 years ago, JYNT has more shares outstanding
There is no outstanding debt for JYNT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
JYNT has an Altman-Z score of 2.83. This is not the best score and indicates that JYNT is in the grey zone with still only limited risk for bankruptcy at the moment.
JYNT has a Altman-Z score of 2.83. This is in the better half of the industry: JYNT outperforms 60.40% of its industry peers.
There is no outstanding debt for JYNT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 2.83 |
ROIC/WACCN/A
WACC8.98%
2.3 Liquidity
A Current Ratio of 1.83 indicates that JYNT should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.83, JYNT is doing good in the industry, outperforming 73.27% of the companies in the same industry.
A Quick Ratio of 1.83 indicates that JYNT should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.83, JYNT is in the better half of the industry, outperforming 76.24% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.83 | ||
| Quick Ratio | 1.83 |
3. Growth
3.1 Past
JYNT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 99.03%, which is quite impressive.
Looking at the last year, JYNT shows a very negative growth in Revenue. The Revenue has decreased by -24.15% in the last year.
The Revenue has been growing slightly by 1.36% on average over the past years.
EPS 1Y (TTM)99.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%109.52%
Revenue 1Y (TTM)-24.15%
Revenue growth 3Y-13.43%
Revenue growth 5Y1.36%
Sales Q2Q%-55.69%
3.2 Future
The Earnings Per Share is expected to grow by 44.54% on average over the next years. This is a very strong growth
JYNT is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -22.13% yearly.
EPS Next Y84.93%
EPS Next 2Y105.18%
EPS Next 3Y44.54%
EPS Next 5YN/A
Revenue Next Year-54.7%
Revenue Next 2Y-30.66%
Revenue Next 3Y-22.13%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
JYNT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 18.16, which indicates a rather expensive current valuation of JYNT.
Based on the Price/Forward Earnings ratio, JYNT is valued a bit cheaper than the industry average as 68.32% of the companies are valued more expensively.
JYNT is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.57, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 18.16 |
4.2 Price Multiples
The rest of the industry has a similar Price/Free Cash Flow ratio as JYNT.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 80.43 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as JYNT's earnings are expected to grow with 44.54% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y105.18%
EPS Next 3Y44.54%
5. Dividend
5.1 Amount
No dividends for JYNT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
8.83
-0.13 (-1.45%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners78.47%
Inst Owner Change0%
Ins Owners22.97%
Ins Owner Change2.03%
Market Cap131.30M
Revenue(TTM)91.63M
Net Income(TTM)-970.20K
Analysts76.36
Price Target10.97 (24.24%)
Short Float %7.28%
Short Ratio7.36
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.07%
Min Revenue beat(2)-2.34%
Max Revenue beat(2)-1.81%
Revenue beat(4)0
Avg Revenue beat(4)-14.21%
Min Revenue beat(4)-51.14%
Max Revenue beat(4)-1.53%
Revenue beat(8)3
Avg Revenue beat(8)-6.24%
Revenue beat(12)3
Avg Revenue beat(12)-4.83%
Revenue beat(16)5
Avg Revenue beat(16)-4.04%
PT rev (1m)0%
PT rev (3m)-27.73%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-54.29%
EPS NY rev (1m)0%
EPS NY rev (3m)-1200%
Revenue NQ rev (1m)-1.72%
Revenue NQ rev (3m)-7.2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.47%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 18.16 | ||
| P/S | 1.43 | ||
| P/FCF | 80.43 | ||
| P/OCF | 42.75 | ||
| P/B | 5.79 | ||
| P/tB | 5.79 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.01
EYN/A
EPS(NY)0.49
Fwd EY5.51%
FCF(TTM)0.11
FCFY1.24%
OCF(TTM)0.21
OCFY2.34%
SpS6.16
BVpS1.53
TBVpS1.53
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.4% | ||
| ROE | -4.27% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 78.26% | ||
| FCFM | 1.78% |
ROA(3y)-7.05%
ROA(5y)1.52%
ROE(3y)-28.39%
ROE(5y)0.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.87%
GM growth 5Y-2.53%
F-Score6
Asset Turnover1.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 78.79% | ||
| Cap/Sales | 1.57% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.83 | ||
| Quick Ratio | 1.83 | ||
| Altman-Z | 2.83 |
F-Score6
WACC8.98%
ROIC/WACCN/A
Cap/Depr(3y)57.36%
Cap/Depr(5y)93.23%
Cap/Sales(3y)6.25%
Cap/Sales(5y)6.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%109.52%
EPS Next Y84.93%
EPS Next 2Y105.18%
EPS Next 3Y44.54%
EPS Next 5YN/A
Revenue 1Y (TTM)-24.15%
Revenue growth 3Y-13.43%
Revenue growth 5Y1.36%
Sales Q2Q%-55.69%
Revenue Next Year-54.7%
Revenue Next 2Y-30.66%
Revenue Next 3Y-22.13%
Revenue Next 5YN/A
EBIT growth 1Y-575.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year312.75%
EBIT Next 3Y60.95%
EBIT Next 5YN/A
FCF growth 1Y-85.24%
FCF growth 3Y6.31%
FCF growth 5Y15.29%
OCF growth 1Y-81.35%
OCF growth 3Y-12.05%
OCF growth 5Y4.6%
JOINT CORP/THE / JYNT FAQ
What is the ChartMill fundamental rating of JOINT CORP/THE (JYNT) stock?
ChartMill assigns a fundamental rating of 4 / 10 to JYNT.
Can you provide the valuation status for JOINT CORP/THE?
ChartMill assigns a valuation rating of 4 / 10 to JOINT CORP/THE (JYNT). This can be considered as Fairly Valued.
How profitable is JOINT CORP/THE (JYNT) stock?
JOINT CORP/THE (JYNT) has a profitability rating of 3 / 10.
How financially healthy is JOINT CORP/THE?
The financial health rating of JOINT CORP/THE (JYNT) is 6 / 10.